Hims & Hers Stock Jumps Ahead of Q3 Earnings on Nov. 9 — Here’s Why
Hims & Hers Health shares ($HIMS) jumped 6% to about $25 on Friday morning, erasing some of the roughly 10% drop the previous day. This followed a ...
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 5,424,027 | $6,276,033,816 | +8% | 1.8% |
| 2. | Leucadia National Ian Cumming And Joseph Steinberg | 53,598 | $62,017,173 | +550% | 0.46% |
| 3. | Locust Wood Capital Advisers Stephen J. Errico | 33,522 | $38,787,670 | -16% | 0.88% |
| 4. | Bourgeon Capital John Zaro | 24,270 | $28,081,987 | -1% | 4.03% |
| 5. | Lee Munder Capital Group Lee Munder | 20,080 | $23,234,166 | -2% | 1.25% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $691.79 | 715 | $494,626.99 | 14,685 | 2025-08-15 | Filing | |
| $660.25 | 758 | $500,472.53 | 758 | 2025-08-13 | Filing | |
| $647.36 | 1,000 | $647,360.00 | 20,562 | 2025-08-13 | Filing | |
| $644.77 | 1,632 | $1,052,263.01 | 546,601 | 2025-08-12 | Filing | |
| $634.41 | 1,000 | $634,405.00 | 137,660 | 2025-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1,402.52 | 5,000 | $7,012,600.00 | 4,137 | 2026-11-02 | Filing | |
| $1,175.10 | 6,500 | $7,638,150.00 | 54,147 | 2026-08-17 | Filing | |
| $1,185.01 | 2,000 | $2,370,020.00 | 1,526 | 2026-08-10 | Filing | |
| $1,190.00 | 5,000 | $5,950,000.00 | 11,875 | 2026-08-07 | Filing | |
| $1,150.77 | 2,500 | $2,876,925.00 | 29,804 | 2026-06-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 90,066,978 | $104,214,698,904 | 100% | |
| 2. | 51,277,245 | $59,331,874,646 | 31.1% | |
| 3. | 20,556,572 | $23,722,722,425 | 1.23% | |
| 4. | 4,745,900 | $5,491,386,649 | 0.9% | |
| 5. | 4,655,456 | $5,386,764,738 | 1.09% |
News See All
Pfizer (PFE) Stock Looks Attractive for Income Investors
Pfizer ($PFE) stock looks attractive for income investors because of its well-covered dividend and modest valuation. The drug maker’s shares have o...
Eli Lilly and Company’s (LLY) GLP-1 Franchise Faces Growing Price Competition
Baron Capital, an investment management company, released its Q3 2026 investor letter for the “Baron Health Care Fund”. The letter can be downloaded here.
3 Healthcare Stocks with ‘Strong Buy’ Analyst Ratings and ‘Perfect 10’ Smart Scores
Eli Lilly ($LLY), UnitedHealth ($UNH), and Gilead Sciences ($GILD) are three healthcare stocks with Strong Buy analyst ratings. All three stocks al...
Eli Lilly Stock (LLY) Soars as Financial Results Crush Wall Street Estimates
The pharma giant raised its sales guidance.
Options Volatility and Implied Earnings Moves Today, October 29, 2026
Today, several major companies are expected to report earnings: Altria Group (MO), Amazon (AMZN), Eli Lilly & Co (LLY), Intel (INTC), Mastercard (M...
Novo Stock (NVO) Falls After Another Head-to-Head Obesity Trial Loss to Eli Lilly
Shares of Danish pharma giant Novo ($NVO) edged lower to around $38 on Wednesday afternoon. This came after rival drugmaker Eli Lilly ($LLY) announ...
Eli Lilly’s (LLY) Head of International Business Retires
The pharma giant reports financial results on Oct. 29.
Jim Cramer is Bullish on These 10 Stocks
Investors are closely watching the artificial intelligence trade amid mounting concerns over massive spending on AI infrastructure, the sustainability of growth and whether companies can generate sufficient...
Wall Street Has High Expectations for Eli Lilly Stock (LLY) Heading into Earnings
The company report earnings on Oct. 29.
Hedge Fund Resource Center